Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
iShares US Healthcare ETF
IYH
$3.5B
| $596K | ﹤0.01% |
10,500
+4,500
| +75% | +$248K |
|
2852
NerdWallet
NRDS
$582M
| $594K | ﹤0.01% |
61,900
-10,900
| -15% | -$122K |
|
2853
Spero Therapeutics
SPRO
$73.5M
| $593K | ﹤0.01% |
342,900
+128,200
| +60% | +$239K |
|
2854
Vanguard Morningstar Large-Cap ETF
VV
$54B
| $592K | ﹤0.01% |
3,400
-400
| -11% | -$70.2K |
|
|
AAN
2855
DELISTED
The Aaron's Company Inc
AAN
| $592K | ﹤0.01% |
49,500
-60,200
| -55% | -$645K |
|
2856
Sotera Health
SHC
$5.39B
| $591K | ﹤0.01% |
71,000
-172,300
| -71% | -$1.29M |
|
|
NWLI
2857
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $590K | ﹤0.01% |
2,100
-1,900
| -48% | -$405K |
|
|
GURE
2858
Gulf Resources
GURE
$4.85M
| $589K | ﹤0.01% |
19,057
-2,450
| -11% | -$83.8K |
|
2859
Shattuck Labs
STTK
$684M
| $589K | ﹤0.01% |
256,300
-8,800
| -3% | -$22K |
|
2860
Dimensional International Core Equity 2 ETF
DFIC
$15B
| $588K | ﹤0.01% |
+26,300
| New | +$562K |
|
2861
i3 Verticals
IIIV
$429M
| $587K | ﹤0.01% |
+24,100
| New | +$544K |
|
|
SURF
2862
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $586K | ﹤0.01% |
714,155
-271,188
| -28% | -$267K |
|
|
KZR
2863
DELISTED
Kezar Life Sciences
KZR
| $585K | ﹤0.01% |
8,310
+3,345
| +67% | +$248K |
|
2864
Mustang Bio
MBIO
$4.36M
| $585K | ﹤0.01% |
1,975
-185
| -9% | -$63.2K |
|
|
AVNS
2865
DELISTED
Avanos Medical
AVNS
| $584K | ﹤0.01% |
+21,600
| New | +$528K |
|
2866
ACNB Corp
ACNB
$661M
| $583K | ﹤0.01% |
14,656
-900
| -6% | -$32.8K |
|
2867
Investar Holding Corp
ISTR
$415M
| $583K | ﹤0.01% |
27,075
+8,900
| +49% | +$191K |
|
|
RWT
2868
Redwood Trust
RWT
$573M
| $582K | ﹤0.01% |
86,100
-11,664
| -12% | -$81.5K |
|
|
FWDI
2869
Forward Industries Inc
FWDI
$307M
| $580K | ﹤0.01% |
54,114
-2,290
| -4% | -$28.5K |
|
2870
Marten Transport
MRTN
$1.21B
| $580K | ﹤0.01% |
29,300
-11,600
| -28% | -$231K |
|
2871
Genasys
GNSS
$80.2M
| $577K | ﹤0.01% |
155,936
-24,606
| -14% | -$71.2K |
|
2872
SelectQuote
SLQT
$120M
| $577K | ﹤0.01% |
859,300
+536,100
| +166% | +$351K |
|
2873
First Bank
FRBA
$458M
| $576K | ﹤0.01% |
41,870
-1,200
| -3% | -$17.7K |
|
|
MITT
2874
TPG Mortgage Investment Trust
MITT
$222M
| $575K | ﹤0.01% |
108,300
+6,900
| +7% | +$35.6K |
|
2875
Bolt Biotherapeutics
BOLT
$7.44M
| $574K | ﹤0.01% |
22,077
+2,384
| +12% | +$65.3K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.